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ABSTRAK
Tujuan: untuk mengetahui hubungan antara kadar hsCRP dan kekakuan arteri pada pasien diabetes melitus 
tipe 2. Metode: melalui studi potong lintang, dilakukan pemeriksaan kadar hsCRP dan derajat kekakuan arteri 
karotis pada 40 pasien dengan diabetes melitus tipe 2. Kekakuan arteri karotis kommunis diperiksa berdasarkan 
radio frequency echotracking system untuk menentukan pulse wave velocity (PWV) atau kekakuan arteri karotis 
lokal (carotid-PWV). Hasil: nilai median hsCRP pada penelitian ini adalah 4,5 (0,2-18,9) mg/L dan nilai rata-
rata kekakuan arteri karotis adalah 8,8±1,7 m/detik. hsCRP berkorelasi kuat dengan karotid-PWV (r=0,503, 
P=0,001). Korelasi hsCRP dengan karotid-PWV ini tetap terlihat setelah dilakukan koreksi terhadap umur, 
indeks masa tubuh dan mean arterial pressure (r = 0,450, P = 0,005). Kesimpulan: hsCRP berkorelasi positif 
sedang dengan kekakuan arteri pada pasien diabetes melitus tipe 2.
Kata kunci: kekakuan arteri, C-reaktif protein.
ABSTRACT
Aim: to identify the correlation between hsCRP and arterial stiffness in type-2 diabetic patients. 
Methods: a cross-sectional study was conducted to assess the plasma levels of hsCRP and carotid arterial 
stiffness in 40 patients with type-2 diabetes mellitus. The common carotid artery stiffness was evaluated using 
radio frequency echo-tracking system to determine the local carotid pulse wave velocity (carotid-PWV). 
Results: median value of hsCRP in this study was 4.5 (0.2 to 18.9) mg/L and the average value of local carotid 
stiffness was 8.8±1.7 m/sec. High sensitive CRP showed a strong correlation with carotid-PWV (r=0.503, 
P=0.001). hsCRP level was independently associated with carotid-PWV after adjustment for age, body mass 
index, and mean arterial pressure (r=0.450, P=0.005). Conclusion: hs-CRP has moderate positive correlation 
with arterial stiffness in patients with type-2 diabets mellitus.
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INTRODUCTION
Cardiovascular disease (CVD) is the main 
cause of morbidity and mortality in patients 
with type-2 diabetes mellitus (T2DM).1 Diabetes 
mellitus is a disease that can activate an acute-
phase reactant, such as C-reactive protein 
(CRP), which is considered as a predictor of 
risk for type-2 DM.2 It has been reported that 
assessment of inflammatory markers such as 
high-sensitivity C-reactive protein (hsCRP) is an 
essential method to identify individuals at risk 
for developing cardiovascular events.3
Increase in arterial stiffness (AS) is 
demonstrated by increased arterial pulse wave 
velocity (PWV). Some epidemiological studies 
suggest that the increased AS can predict 
cardiovascular (CV) mortality and morbidity 
independent of other CV risk factors.4 The 
Framingham Heart Study demonstrates that 
measurement of PWV may be helpful to achieve 
target of preventing the development of CV 
events in those who have some risk factors.5
Pulse wave velocity is the speed of pulse 
wave going out through the aorta.6,7 Carotid-
femoral pulse wave velocity (cf-PWV) 
has been established as the gold standard 
evaluation for arterial stiffness. However, 
the cf-PWV measurement may not reflect 
the real pathophysiological condition of AS. 
The distance between carotid and femoral is 
measured manually and it may be different from 
the real length of arterial line due to anatomical 
variety.8 Stenosis or narrowing in aortic, iliac, 
and proximal femoral arteries may weaken 
and inhibit the pressure wave. Central obesity, 
particularly in men and women with big-sized 
breasts, may cause the distance measurement 
to be inaccurate.9 Advances in ultrasonography 
have brought a new development of AS local 
measuring method using the radio frequency 
(RF) echotracking system; therefore, the 
technical problems in regional measurement 
can be overcome. The RF echotracking system 
can measure the change of diameter on altered 
pressure and volume against the vascular wall, 
which allow local measurement of PWV; thus, 
it may overcome drawbacks and limitations of 
regional AS measurement.9,10
Available reports on arterial stiffness are 
hitherto always use regional measurement.11-19 
The present study is the first study observing 
the correlation between hsCRP and AS through 
local measurement using radio frequency (RF) 
echotracking system. The aim of the study was 
to identify the correlation between hsCRP levels 
and arterial stiffness in patients with type 2 
diabetes mellitus.
METHODS
This was a cross-sectional study on 40 type-2 
diabetic patients aged between 40-60 year who 
willing to participate in this study and visited our 
department between March and May 2014 using 
consecutive sampling. Subjects with heart rhythm 
disorder, heart failure, carotid arterial stenosis, 
cancer, infectious disease/acute inflammation, 
renal dysfunction (GFR<60 ml/minutes/1.73 
m²) and those who were unable to lay down 
or disturbing local cervical problems or with 
contraindication for physical examination (mass, 
ulcer, cervical fixation, cervical osteoarthritis, etc) 
were excluded from the study.
Blood samples were taken from antecubital 
vein after overnight fasting. All patients 
underwent laboratory examinations including 
total cholesterol, triglycerides (TG), high-density 
lipoprotein (HDL), low-density lipoprotein 
(LDL), fasting blood glucose (FBG), 2-hour post-
prandial blood glucose (2hPPBG), glycosylated 
hemoglobin (HbA1c), uric acid and hsCRP level. 
Measurements of arterial stiffness were performed 
by automatic resolution echotracking system 
radio frequency based on ultrasound method 
using ESAOTE MyLab 70 QAS machine, which 
utlilized linear probe of 10-12 MHz 124 RF-lines.
Measurements were performed on left 
and right common carotid arteries at 1 cm 
proximal to the bifurcation in order to avoid 
the effect of complex flow in carotid sinus. 
Scanning was performed on common carotid 
arterial wall through antero-lateral approach. 
The results of measurements were mean of 
6 taps of examination. The examination was 
considered valid when the SD of distension was 
<20 μm. Results of measurement on vascular 
diameters and distensions combined with data 
of blood pressure were subsequently processed 
by the ultrasound machine which gave results 
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about carotid arterial stiffness in the form of 
pulse wave velocity.6,10 Mean values of left-
right carotid arteries were used as the values 
representing each individual. Measurement 
of AS using the radio frequency echotracking 
system had a low intraobserver variability.10
All statistical tests were performed using 
SPSS 20 for Windows. Shapiro-Wilk normality 
test was performed to identify the normality of 
data distribution. Data with normal distribution 
was expressed in mean value and standard 
deviation; while data with abnormal distribution 
was expressed in median, maximal and minimal 
value. Data transformation was conducted 
before performing correlation test in order to 
normalize the data distribution. Correlation test 
were performed by using Pearson or Spearman 
correlation test, as appropriate. In order to find a 
pure correlation between hsCRP level and AS, a 
partial correlation analysis was performed. The 
significance level of 95% was used.
RESULTS
Basic characteristics of participants are 
shown in Table 1. Mean value of arterial 
stiffness in the subjects was 8.8±1.7 m/second. 
The mean value of hsCRP level in this study 
was 5.8 mg/L with a median of 4.5 mg/L (range: 
0.2–18.9).
Bivariate analysis showed a strong correlation 
between hsCRP level and AS with r=0.503 and 
p=0.001) (Figure 1). In addition, the correlation 
between various associated variables and arterial 
stiffness can be seen in Table 2. 
There was a significant correlation between 
AK and age, BMI, as well as MAP. Furthermore, 
after a correction was done for variables of 
age, BMI and MAP, there was still a moderate 
correlation between hsCRP level and AS 
(r=0.450, P=0.005), with R Square value (R2) 
of 20.3%.
DISCUSSION
In the present study, manifestation of arterial 
stiffness was evaluated using carotid pulse 
wave velocity by local measurement method on 
carotid arterial wall. The mean value of arterial 
stiffness in the study was 8.8±1.7 m/second. 
Table 1. Subject characteristics
Variables n (%) Mean (SD) Median (range)
Age 53.3 (40-60)
Sex:
 - Male 14 (35)
 - Female 26 (65)
hsCRP level 
(mg/L)
4.5  
(0.2–18.9)
AS (PWV)  
(m/second)
8.8 (1.7)
BMI (kg/m2) 26.3 (4.7)
SBP (mmHg) 137.7(19.2)
DBP (mmHg) 79.0 (10.0)
MAP (mmHg) 98.0  
(81.6-131.3)
Total cholesterol 
(mg/dl)
197.9(55.8)
LDL (mg/dl) 112.5  
(60-268)
HDL (mg/dl) 45.3 (11.3)
TG (mg/dl) 132.5 
(30–686)
UA (mg/dl) 6.1 (2.1)
FBG (mg/dl) 119.5 
(83–383)
2hPPBG  
(mg/dl)
202.0 
(45–521)
HbA1c (%) 8.6 (2.1)
Figure 1. Correlation between log hsCRP level and arterial 
stiffness (r =0.503, P=0.001)
Gasner et al20 reported that carotid PWV in 
CHD patients was significantly higher than the 
control group, i.e. 7.4±1.3 m/second vs 6.5 ±1.1 
m/second (p<0.01).
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BaPWV) and hsCRP levels (r=0.341, P=0.016) 
after being adjusted for age. Yasmin et al.12 
reported that aortic PWV in healthy individuals 
is independently correlated with age, male sex, 
MAP and CRP. Likewise, brachial PWV is 
correlated with age, MAP, CRP, male sex, TG, 
HDL and smoking. Anan et al13 who conducted 
a study in T2DM Japanese patients reported that 
in the bivariate and multivariate analysis, there 
were a correlation between BaPWV and hsCRP 
level. Tomiyama et al14 reported that BaPWV is 
significantly correlated to hsCRP level in healthy 
Japanese individuals. Kim et al.15 reported that 
hsCRP level is significantly correlated to Heart 
to femoral PWV (hfPWV) and brachial to ankle 
PWV (baPWV) in patients with non-diabetic 
hypertension. While London et al16 found that 
there is a correlation between aortic PWV and 
CRP in patients with end-stage renal failure and 
there is an inverse correlation between CRP 
level and the effectiveness of antihypertension 
treatment. Gomez-Marcos et al17 reported that in 
patients with hypertension there is a significant 
correlation between hsCRP and PWV after 
adjustment with age, cardiovascular risk factors 
and the use of antihypertension and anti-lipid 
agents. Moreover, Llaurado et al18 showed a 
significant correlation between aortic PWV 
and hsCRP in type-1 DM patients without 
cardiovascular disease.
Different results are reported by Sung et 
al19 who did not find a significant correlation 
between hsCRP and baPWV in common 
Chinese population. Important findings found 
in this study shows that in T2DM patients, there 
is a significant correlation between AS and 
hsCRP level after an adjustment with age and 
cardiovascular risk factors. These data indicate 
that AS is correlated to systemic inflammation 
and the inflammation plays an important role in 
the development of arterial wall stiffeness.
CRP may induce atherosclerosis through 
various ways. It activates platelet complement 
and induces cytokines expressions. Activated 
complement platelet-activating factor cytokines 
will stimulate leukocytes to release radical 
oxygen. CRP also increases generation of free-
radical oxygen by monocytes and neutrophils. 
Radical oxygen has been known to be involved 
Table 2. Correlation between associated variables and 
arterial stiffness
Risk Factors
AS (PWV)
r p
Age 0.422 0.007
BMI 0.332 0.036
MAP 0.380 0.016
LDL 0.130 0.423
HbA1c 0.116 0.484
HbA1c, glycated hemoglobini; AS, arterial stiffness; 
LDL, Low-density lipoprotein; BMI, body mass index; 
MAP, mean arterial pressure;  PWV, pulse wave 
velocity
Mean hsCRP level in this study was 5.8 mg/L 
with median of 4.5 (0.2–18.9). These results 
are similar to a report by Nandyala et al.21 that 
found hsCRP level in male diabetic patients of 
4.88±2.02 mg/L and 5.12±2.14 mg/L in female 
patients; while for the non-diabetic patients, the 
hsCRP level was 1.24±0.56 mg/L. Likewise 
on a report of Mojahedi et al.22 hsCRP level in 
diabetic patients with microalbuminuria was 
4.98±1.45 (0.6–7.3) mg/L, a lower level was 
found in diabetic patients without albuminuria, 
i.e. 2.82±2.10 (0–7.0) mg/L. The hsCRP levels 
in the present study was higher than a study 
conducted Mahajan et al23 who reported hsCRP 
level in T2DM patients of Indian ethnicity was 
1.58 mg/L (0.65–3.49) in male subjects and 2.68 
mg/L (1.28–4.94) in female subjects. Previous 
studies in subjects with metabolic syndrome 
found that the mean value of hsCRP level ranged 
between 2.0 and 2.7 mg/L.24-26 While Oh et al.11 
reported that the mean value of hsCRP level in 
female subjects with metabolic syndrome was 
1.2 mg/L.
On bivariate analysis, there were a significant 
correlation between hsCRP levels and AS 
(r=0.503, P=0.001), age (r=0.422, P=0.007), BMI 
(r=0.332, P=0.036) and MAP (r=0.380, P=0.016). 
There was no significant correlation between AS 
and HbA1c as well as with LDL. The correlation 
between hsCRP levels and AS was still significant 
after an adjustment on variables of age, BMI and 
MAP (r=0.450, P=0.005).
Previously, Oh et al.11 conducted a study in 
women with metabolic syndrome and found that 
there is a correlation between AS (measured by 
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in pathophysiology of atherosclerosis. The 
hypothesis of oxidative atherosclerosis depends 
on radical oxygen. Adhesion cellular molecules 
are involved in atherogenesis. CRP induces 
expressions of adhesion molecules in endothelial 
cells and monocyte chemotactic protein-1 (MCP-
1). Radical oxygen produced by CRP may also 
increase the expression of adhesion molecules, 
which is modulated by free radical and oxidative 
stress and suppressed by antioxidants.27 CRP 
works on smooth muscle cells in blood vessels 
and performs upregulating type of angiotensin 
I receptor. It also stimulates migration and 
proliferation of smooth muscle cells and 
produces reactive oxygen species (ROS).28 Since 
such endothelial dysregulation may cause arterial 
vasoconstricition, proliferation of smooth muscle 
cells and vascular inflammation, increased 
CRP level may increase vascular stiffness 
and aggrevate further vascular inflammation. 
Therefore, this acute-phase reactant protein is 
not only an inflammatory marker, but may also 
have modulating function, which contributes to 
the development and evolution of atherosclerosis 
and increases arterial vascular stiffness.
CONCLUSION 
From this study, it can be concluded that 
high-sensitivity C-reactive protein has a positive 
moderate correlation with arterial stiffness in 
T2DM patients.
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